Long-term persistence of neutralizing SARS-CoV-2 antibodies in pets.

Nicola DecaroAndrea GrassiEleonora LorussoEdward I PattersonAlessio LorussoCostantina DesarioEnyia R AndersonVioletta VasiniotiChristida E WastikaGrant L HughesFabrizia VallerianiBarbara ColittiDominga RicciDomenico BuonavogliaSergio RosatiNicola CavaliereSaverio PaltrinieriStefania Lauzi Gabriella EliaCanio Buonavoglia

Published in: Transboundary and emerging diseases (2021)

We monitored the severe acute respiratory syndrome coronavirus 2 antibody response in seven dogs and two cats by using two multispecies ELISA tests, plaque reduction neutralisation test and virus neutralization. SARS-CoV-2 neutralizing antibodies in pets persisted up to 10 months since the first positive testing, thus replicating observations in COVID-19 human patients.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
coronary artery disease
dengue virus
prognostic factors
peritoneal dialysis
induced pluripotent stem cells
pluripotent stem cells